 | • レポートコード：B-GIR08C5632 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、交感神経興奮薬の世界市場について調べ、まとめました。種類別セグメントは、ドブタミン、ドーパミン、エフェドリン、エピネフリン、イソプロテレノール、メフェンテルミン、メタラミノール、メトキサミン、ノルエピネフリン、フェニレフリン等、用途別セグメントは、等に区分しました。交感神経興奮薬の世界市場概観、企業動向、企業別交感神経興奮薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・交感神経興奮薬の市場概観 ・交感神経興奮薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・交感神経興奮薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・交感神経興奮薬の世界市場規模 ・交感神経興奮薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・交感神経興奮薬のアメリカ市場規模推移 ・交感神経興奮薬のカナダ市場規模推移 ・交感神経興奮薬のメキシコ市場規模推移 ・交感神経興奮薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・交感神経興奮薬のドイツ市場規模推移 ・交感神経興奮薬のイギリス市場規模推移 ・交感神経興奮薬のロシア市場規模推移 ・交感神経興奮薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・交感神経興奮薬の日本市場規模推移 ・交感神経興奮薬の中国市場規模推移 ・交感神経興奮薬の韓国市場規模推移 ・交感神経興奮薬のインド市場規模推移 ・交感神経興奮薬の東南アジア市場規模推移 ・交感神経興奮薬の南米市場分析（ブラジル、アルゼンチン等） ・交感神経興奮薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・交感神経興奮薬の種類別分析/販売量、売上、市場シェア（ドブタミン、ドーパミン、エフェドリン、エピネフリン、イソプロテレノール、メフェンテルミン、メタラミノール、メトキサミン、ノルエピネフリン、フェニレフリン） ・交感神経興奮薬の用途別分析/市場規模（） ・交感神経興奮薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・交感神経興奮薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Sympathomimetic Agents market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Sympathomimetic Agents.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Sympathomimetic Agents market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Sympathomimetic Agents market by product type and applications/end industries.
Market Segment by Companies, this report covers
Pfizer
Sanofi
Novartis
Sterimax
Bedford Pharmaceuticals
Teva
Amneal Biosciences
Baxter Laboratories
Hikma Pharmaceuticals
Amphastar Pharmaceuticals
Marathon Pharmaceuticals
Bausch Health Companies
Sterling-Winthrop
Cipla USA
Nexus Pharmaceuticals
Mylan
Impax
ALK Abello
Lincoln Medical
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao Group
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Dobutamine
Dopamine
Ephedrine
Epinephrine
Isoproterenol
Mephentermine
Metaraminol
Methoxamine
Norepinephrine
Phenylephrine
Market Segment by Applications, can be divided into
Anaphylaxis
Cardiac Arrest
Others
Table of Contents
1 Sympathomimetic Agents Market Overview
1.1 Product Overview and Scope of Sympathomimetic Agents
1.2 Classification of Sympathomimetic Agents by Types
1.2.1 Global Sympathomimetic Agents Revenue Comparison by Types (2019-2024)
1.2.2 Global Sympathomimetic Agents Revenue Market Share by Types in 2018
1.2.3 Dobutamine
1.2.4 Dopamine
1.2.5 Ephedrine
1.2.6 Epinephrine
1.2.7 Isoproterenol
1.2.8 Mephentermine
1.2.9 Metaraminol
1.2.10 Methoxamine
1.2.11 Norepinephrine
1.2.12 Phenylephrine
1.3 Global Sympathomimetic Agents Market by Application
1.3.1 Global Sympathomimetic Agents Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Anaphylaxis
1.3.3 Cardiac Arrest
1.3.4 Others
1.4 Global Sympathomimetic Agents Market by Regions
1.4.1 Global Sympathomimetic Agents Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Sympathomimetic Agents Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Sympathomimetic Agents Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sympathomimetic Agents Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Sympathomimetic Agents Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sympathomimetic Agents Status and Prospect (2014-2024)
1.5 Global Market Size of Sympathomimetic Agents (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Sympathomimetic Agents Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Sympathomimetic Agents Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Sympathomimetic Agents Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sterimax
2.4.1 Business Overview
2.4.2 Sympathomimetic Agents Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sterimax Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.5 Bedford Pharmaceuticals
2.5.1 Business Overview
2.5.2 Sympathomimetic Agents Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bedford Pharmaceuticals Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.6 Teva
2.6.1 Business Overview
2.6.2 Sympathomimetic Agents Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Teva Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.7 Amneal Biosciences
2.7.1 Business Overview
2.7.2 Sympathomimetic Agents Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Amneal Biosciences Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.8 Baxter Laboratories
2.8.1 Business Overview
2.8.2 Sympathomimetic Agents Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Baxter Laboratories Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.9 Hikma Pharmaceuticals
2.9.1 Business Overview
2.9.2 Sympathomimetic Agents Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Hikma Pharmaceuticals Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.10 Amphastar Pharmaceuticals
2.10.1 Business Overview
2.10.2 Sympathomimetic Agents Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Amphastar Pharmaceuticals Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.11 Marathon Pharmaceuticals
2.11.1 Business Overview
2.11.2 Sympathomimetic Agents Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Marathon Pharmaceuticals Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.12 Bausch Health Companies
2.12.1 Business Overview
2.12.2 Sympathomimetic Agents Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Bausch Health Companies Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.13 Sterling-Winthrop
2.13.1 Business Overview
2.13.2 Sympathomimetic Agents Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Sterling-Winthrop Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.14 Cipla USA
2.14.1 Business Overview
2.14.2 Sympathomimetic Agents Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Cipla USA Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.15 Nexus Pharmaceuticals
2.15.1 Business Overview
2.15.2 Sympathomimetic Agents Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Nexus Pharmaceuticals Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.16 Mylan
2.16.1 Business Overview
2.16.2 Sympathomimetic Agents Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Mylan Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.17 Impax
2.17.1 Business Overview
2.17.2 Sympathomimetic Agents Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Impax Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.18 ALK Abello
2.18.1 Business Overview
2.18.2 Sympathomimetic Agents Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 ALK Abello Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.19 Lincoln Medical
2.19.1 Business Overview
2.19.2 Sympathomimetic Agents Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Lincoln Medical Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.20 Amphastar
2.20.1 Business Overview
2.20.2 Sympathomimetic Agents Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Amphastar Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.21 Emerade
2.21.1 Business Overview
2.2.2 Sympathomimetic Agents Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Emerade Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.22 Grand Pharma
2.22.1 Business Overview
2.22.2 Sympathomimetic Agents Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Grand Pharma Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.23 Harvest Pharmaceuticals
2.23.1 Business Overview
2.23.2 Sympathomimetic Agents Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Harvest Pharmaceuticals Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.24 Merit Pharmaceutical
2.24.1 Business Overview
2.24.2 Sympathomimetic Agents Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Merit Pharmaceutical Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.25 Tianjin Jinyao Group
2.25.1 Business Overview
2.25.2 Sympathomimetic Agents Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Tianjin Jinyao Group Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
3 Global Sympathomimetic Agents Market Competition, by Players
3.1 Global Sympathomimetic Agents Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Sympathomimetic Agents Players Market Share
3.2.2 Top 10 Sympathomimetic Agents Players Market Share
3.3 Market Competition Trend
4 Global Sympathomimetic Agents Market Size by Regions
4.1 Global Sympathomimetic Agents Revenue and Market Share by Regions
4.2 North America Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
4.3 Europe Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
4.5 South America Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
5 North America Sympathomimetic Agents Revenue by Countries
5.1 North America Sympathomimetic Agents Revenue by Countries (2014-2019)
5.2 USA Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
5.3 Canada Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
5.4 Mexico Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
6 Europe Sympathomimetic Agents Revenue by Countries
6.1 Europe Sympathomimetic Agents Revenue by Countries (2014-2019)
6.2 Germany Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
6.3 UK Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
6.4 France Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
6.5 Russia Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
6.6 Italy Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Sympathomimetic Agents Revenue by Countries
7.1 Asia-Pacific Sympathomimetic Agents Revenue by Countries (2014-2019)
7.2 China Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
7.3 Japan Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
7.4 Korea Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
7.5 India Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
8 South America Sympathomimetic Agents Revenue by Countries
8.1 South America Sympathomimetic Agents Revenue by Countries (2014-2019)
8.2 Brazil Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
8.3 Argentina Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
8.4 Colombia Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Sympathomimetic Agents by Countries
9.1 Middle East and Africa Sympathomimetic Agents Revenue by Countries (2014-2019)
9.2 Saudi Arabia Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
9.3 UAE Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
9.4 Egypt Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
9.5 Nigeria Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
9.6 South Africa Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
10 Global Sympathomimetic Agents Market Segment by Type
10.1 Global Sympathomimetic Agents Revenue and Market Share by Type (2014-2019)
10.2 Global Sympathomimetic Agents Market Forecast by Type (2019-2024)
10.3 Dobutamine Revenue Growth Rate (2014-2024)
10.4 Dopamine Revenue Growth Rate (2014-2024)
10.5 Ephedrine Revenue Growth Rate (2014-2024)
10.6 Epinephrine Revenue Growth Rate (2014-2024)
10.7 Isoproterenol Revenue Growth Rate (2014-2024)
10.8 Mephentermine Revenue Growth Rate (2014-2024)
10.9 Metaraminol Revenue Growth Rate (2014-2024)
10.10 Methoxamine Revenue Growth Rate (2014-2024)
10.11 Norepinephrine Revenue Growth Rate (2014-2024)
10.12 Phenylephrine Revenue Growth Rate (2014-2024)
11 Global Sympathomimetic Agents Market Segment by Application
11.1 Global Sympathomimetic Agents Revenue Market Share by Application (2014-2019)
11.2 Sympathomimetic Agents Market Forecast by Application (2019-2024)
11.3 Anaphylaxis Revenue Growth (2014-2019)
11.4 Cardiac Arrest Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Sympathomimetic Agents Market Size Forecast (2019-2024)
12.1 Global Sympathomimetic Agents Market Size Forecast (2019-2024)
12.2 Global Sympathomimetic Agents Market Forecast by Regions (2019-2024)
12.3 North America Sympathomimetic Agents Revenue Market Forecast (2019-2024)
12.4 Europe Sympathomimetic Agents Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Sympathomimetic Agents Revenue Market Forecast (2019-2024)
12.6 South America Sympathomimetic Agents Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Sympathomimetic Agents Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Sympathomimetic Agents Picture
Table Product Specifications of Sympathomimetic Agents
Table Global Sympathomimetic Agents and Revenue (Million USD) Market Split by Product Type
Figure Global Sympathomimetic Agents Revenue Market Share by Types in 2018
Figure Dobutamine Picture
Figure Dopamine Picture
Figure Ephedrine Picture
Figure Epinephrine Picture
Figure Isoproterenol Picture
Figure Mephentermine Picture
Figure Metaraminol Picture
Figure Methoxamine Picture
Figure Norepinephrine Picture
Figure Phenylephrine Picture
Table Global Sympathomimetic Agents Revenue (Million USD) by Application (2014-2024)
Figure Sympathomimetic Agents Revenue Market Share by Applications in 2018
Figure Anaphylaxis Picture
Figure Cardiac Arrest Picture
Figure Others Picture
Table Global Market Sympathomimetic Agents Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Sympathomimetic Agents Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Sympathomimetic Agents Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Sympathomimetic Agents Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Sympathomimetic Agents Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Sympathomimetic Agents Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Sympathomimetic Agents Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Sympathomimetic Agents Type and Applications
Table Pfizer Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Sympathomimetic Agents Type and Applications
Table Sanofi Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Sympathomimetic Agents Type and Applications
Table Novartis Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Sterimax Basic Information, Manufacturing Base and Competitors
Table Sterimax Sympathomimetic Agents Type and Applications
Table Sterimax Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Bedford Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Bedford Pharmaceuticals Sympathomimetic Agents Type and Applications
Table Bedford Pharmaceuticals Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Sympathomimetic Agents Type and Applications
Table Teva Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Amneal Biosciences Basic Information, Manufacturing Base and Competitors
Table Amneal Biosciences Sympathomimetic Agents Type and Applications
Table Amneal Biosciences Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Baxter Laboratories Basic Information, Manufacturing Base and Competitors
Table Baxter Laboratories Sympathomimetic Agents Type and Applications
Table Baxter Laboratories Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Hikma Pharmaceuticals Sympathomimetic Agents Type and Applications
Table Hikma Pharmaceuticals Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Amphastar Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Amphastar Pharmaceuticals Sympathomimetic Agents Type and Applications
Table Amphastar Pharmaceuticals Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Marathon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Marathon Pharmaceuticals Sympathomimetic Agents Type and Applications
Table Marathon Pharmaceuticals Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Bausch Health Companies Basic Information, Manufacturing Base and Competitors
Table Bausch Health Companies Sympathomimetic Agents Type and Applications
Table Bausch Health Companies Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Sterling-Winthrop Basic Information, Manufacturing Base and Competitors
Table Sterling-Winthrop Sympathomimetic Agents Type and Applications
Table Sterling-Winthrop Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla USA Basic Information, Manufacturing Base and Competitors
Table Cipla USA Sympathomimetic Agents Type and Applications
Table Cipla USA Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Nexus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Nexus Pharmaceuticals Sympathomimetic Agents Type and Applications
Table Nexus Pharmaceuticals Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Sympathomimetic Agents Type and Applications
Table Mylan Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Impax Basic Information, Manufacturing Base and Competitors
Table Impax Sympathomimetic Agents Type and Applications
Table Impax Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table ALK Abello Basic Information, Manufacturing Base and Competitors
Table ALK Abello Sympathomimetic Agents Type and Applications
Table ALK Abello Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Lincoln Medical Basic Information, Manufacturing Base and Competitors
Table Lincoln Medical Sympathomimetic Agents Type and Applications
Table Lincoln Medical Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Amphastar Basic Information, Manufacturing Base and Competitors
Table Amphastar Sympathomimetic Agents Type and Applications
Table Amphastar Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Emerade Basic Information, Manufacturing Base and Competitors
Table Emerade Sympathomimetic Agents Type and Applications
Table Emerade Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Grand Pharma Basic Information, Manufacturing Base and Competitors
Table Grand Pharma Sympathomimetic Agents Type and Applications
Table Grand Pharma Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Harvest Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Harvest Pharmaceuticals Sympathomimetic Agents Type and Applications
Table Harvest Pharmaceuticals Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Merit Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Merit Pharmaceutical Sympathomimetic Agents Type and Applications
Table Merit Pharmaceutical Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Tianjin Jinyao Group Basic Information, Manufacturing Base and Competitors
Table Tianjin Jinyao Group Sympathomimetic Agents Type and Applications
Table Tianjin Jinyao Group Sympathomimetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Global Sympathomimetic Agents Revenue (Million USD) by Players (2014-2019)
Table Global Sympathomimetic Agents Revenue Share by Players (2014-2019)
Figure Global Sympathomimetic Agents Revenue Share by Players in 2017
Figure Global Sympathomimetic Agents Revenue Share by Players in 2018
Figure Global Top 5 Players Sympathomimetic Agents Revenue Market Share in 2018
Figure Global Top 10 Players Sympathomimetic Agents Revenue Market Share in 2018
Figure Global Sympathomimetic Agents Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Sympathomimetic Agents Revenue (Million USD) by Regions (2014-2019)
Table Global Sympathomimetic Agents Revenue Market Share by Regions (2014-2019)
Figure Global Sympathomimetic Agents Revenue Market Share by Regions (2014-2019)
Figure Global Sympathomimetic Agents Revenue Market Share by Regions in 2018
Figure North America Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Figure Europe Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Figure South America Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Table North America Sympathomimetic Agents Revenue by Countries (2014-2019)
Table North America Sympathomimetic Agents Revenue Market Share by Countries (2014-2019)
Figure North America Sympathomimetic Agents Revenue Market Share by Countries (2014-2019)
Figure North America Sympathomimetic Agents Revenue Market Share by Countries in 2018
Figure USA Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Figure Canada Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Figure Mexico Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Table Europe Sympathomimetic Agents Revenue (Million USD) by Countries (2014-2019)
Figure Europe Sympathomimetic Agents Revenue Market Share by Countries (2014-2019)
Figure Europe Sympathomimetic Agents Revenue Market Share by Countries in 2018
Figure Germany Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Figure UK Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Figure France Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Figure Russia Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Figure Italy Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Sympathomimetic Agents Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Sympathomimetic Agents Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Sympathomimetic Agents Revenue Market Share by Countries in 2018
Figure China Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Figure Japan Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Figure Korea Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Figure India Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Table South America Sympathomimetic Agents Revenue by Countries (2014-2019)
Table South America Sympathomimetic Agents Revenue Market Share by Countries (2014-2019)
Figure South America Sympathomimetic Agents Revenue Market Share by Countries (2014-2019)
Figure South America Sympathomimetic Agents Revenue Market Share by Countries in 2018
Figure Brazil Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Figure Argentina Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Figure Colombia Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Sympathomimetic Agents Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Sympathomimetic Agents Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Sympathomimetic Agents Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Sympathomimetic Agents Revenue Market Share by Countries in 2018
Figure Saudi Arabia Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Figure UAE Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Figure Egypt Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Figure Nigeria Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Figure South Africa Sympathomimetic Agents Revenue and Growth Rate (2014-2019)
Table Global Sympathomimetic Agents Revenue (Million USD) by Type (2014-2019)
Table Global Sympathomimetic Agents Revenue Share by Type (2014-2019)
Figure Global Sympathomimetic Agents Revenue Share by Type (2014-2019)
Figure Global Sympathomimetic Agents Revenue Share by Type in 2018
Table Global Sympathomimetic Agents Revenue Forecast by Type (2019-2024)
Figure Global Sympathomimetic Agents Market Share Forecast by Type (2019-2024)
Figure Global Dobutamine Revenue Growth Rate (2014-2019)
Figure Global Dopamine Revenue Growth Rate (2014-2019)
Figure Global Ephedrine Revenue Growth Rate (2014-2019)
Figure Global Epinephrine Revenue Growth Rate (2014-2019)
Figure Global Isoproterenol Revenue Growth Rate (2014-2019)
Figure Global Mephentermine Revenue Growth Rate (2014-2019)
Figure Global Metaraminol Revenue Growth Rate (2014-2019)
Figure Global Methoxamine Revenue Growth Rate (2014-2019)
Figure Global Norepinephrine Revenue Growth Rate (2014-2019)
Figure Global Phenylephrine Revenue Growth Rate (2014-2019)
Table Global Sympathomimetic Agents Revenue by Application (2014-2019)
Table Global Sympathomimetic Agents Revenue Share by Application (2014-2019)
Figure Global Sympathomimetic Agents Revenue Share by Application (2014-2019)
Figure Global Sympathomimetic Agents Revenue Share by Application in 2018
Table Global Sympathomimetic Agents Revenue Forecast by Application (2019-2024)
Figure Global Sympathomimetic Agents Market Share Forecast by Application (2019-2024)
Figure Global Anaphylaxis Revenue Growth Rate (2014-2019)
Figure Global Cardiac Arrest Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Sympathomimetic Agents Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Sympathomimetic Agents Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Sympathomimetic Agents Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Sympathomimetic Agents Revenue Market Forecast (2019-2024)
Figure Europe Sympathomimetic Agents Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Sympathomimetic Agents Revenue Market Forecast (2019-2024)
Figure South America Sympathomimetic Agents Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Sympathomimetic Agents Revenue Market Forecast (2019-2024)
世界の浮選剤市場2019 The global Flotation Agents market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Flotation Agents market status and forecast, categorizes the global Flotation Agents market size (value & volume) …- 世界のマイクロバブル/超音波造影剤市場：市場規模・現状・予測 Microbubbles/ultrasound contrast agents are small spherical bubbles comprised of three phases, namely innermost gas phase, shell material enclosing the gas phase, and outermost gas or liquid phase. These microbubbles have unique ability to respond to ultrasound; thereby used for ultrasound imaging a…
- 抗腫瘍薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Anti-neoplastic are the drugs that prevent growth of any abnormal tissue leading to cancer. The drugs pass into the human body and destroy cancerous cells. These drugs are also used in conjunction with surgery, radiotherapy and immunotherapy for solid tumors. The anti-neoplastic pharmaceutical agent…
- 抗微生物剤市場：世界及び中国の市場分析・予測（～2024年） Antimicrobial Agents Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Antimicrobial Agents industry with a focus on the Chinese market. The report provides key statistics on the market status of the Antimicrobial Agents manufac…
- 透析剤市場：世界及び中国の市場分析・予測（～2024年） Dialysis Agents Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Dialysis Agents industry with a focus on the Chinese market. The report provides key statistics on the market status of the Dialysis Agents manufacturers and is a…